The aim of this study was to examine the impact of well-controlled uncomplicated type 2 diabetes (T2D) on exercise performance. Six obese sedentary men with T2D and 7 control participants without diabetes matched for age, sex and body mass index were recruited.
Introduction
The presence of type 2 diabetes, with or without cardiovascular complications, is often associated with reduced maximal oxygen uptake (VO 2 max) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) . Type 2 diabetes also seems to affect submaximal VO 2 response, however, results are equivocal. A study conducted in older men (65 ± 5 years) with well-controlled type 2 diabetes and long disease duration (> 5 years) (9) reported no difference in VO 2 kinetics compared to control participants without diabetes, while others reported a slower VO 2 kinetics in pre-and postmenopausal women (4, 7, 10) , adolescents with type 2 diabetes (6) and middle-aged men with type 2 diabetes (10, 15) . Taken together, these findings support the fact that this metabolic disorder eventually affects negatively numerous human body functions depending on patients' glycemic control, disease duration as well as the presence of comorbidities due to diabetes. Whether abnormal exercise capacity is the result of type 2 diabetes per se or a consequence of its associated comorbidities is not clear, as most of the studies on men have been conducted in patients with type 2 diabetes without optimal glycemic control (9, 10) . Evidence of subclinical abnormalities in autonomic (17) and cardiac function (18) (19) (20) (21) have been reported in patients with diabetes. Reduced heart rate variability (22) , left ventricular diastolic dysfunction (23) and lower lung capacity (24) have all been associated with reduced maximal exercise capacity in patients with type 2 diabetes. Still, the influence of type 2 diabetes per se on VO 2 and HR kinetics in uncomplicated well-controlled middle-aged men remains unknown.
The aim of this study was to evaluate the impact of well-controlled, uncomplicated type 2 diabetes on VO 2 max as well as VO 2 and HR kinetics in obese sedentary middle-aged type 2 diabetes men compared to control participants matched for sex, age and body mass index. A secondary objective of this study was to provide an integrative view of the impact of type 2 diabetes, including metabolic control, lipid profile, cardiopulmonary function, cardiac structures, and heart rate variability, in relationship to exercise performance. We hypothesized that the presence of well-controlled, uncomplicated type 2 diabetes would be associated with a reduction in VO 2 max but similar VO 2 and HR kinetics compared to participants without diabetes.
Methods

Study population
Six sedentary men with type 2 diabetes and 7 control participants without diabetes matched for age, sex, and body mass index were recruited for this study. This control group, which represents a real life situation considering the impacts of an inactive lifestyle, age and overweight/obesity on human body systems and exercise performance (25) (26) (27) , strengthen the study design. Type 2 diabetes was diagnosed according to American Diabetes Association criteria (28) . All subjects with diabetes were managed with diet, except two who were treated with metformin alone. No participants were using insulin or any cardiovascular drug regimen for the treatment of other diseases/comorbidities. Exclusion criteria for both groups were the documented presence of cardiovascular disease, a documented office blood pressure above 140/90 mmHg and clinically significant end-organ complications related to diabetes, i.e. renal failure (creatinine above normal upper limit), macroalbuminuria, proliferative retinopathy, clinically significant sensitive, motor or autonomic neuropathies as well as the participation to a structured exercise training program.
The local ethics committee approved the study, in accordance with the Helsinki declaration, and all participants gave signed informed consent.
Study design
Participants visited our laboratory on 5 different occasions. Blood profile and a resting echocardiographic variables, pulmonary function, heart rate variability, and VO 2 max were evaluated on the first visit (V 1 ). Then, participants performed square-wave transitions from unloaded pedaling to moderate-intensity exercise on four different visits separated by 48 hours (V 2 -V 5 ) to determine VO 2 and HR kinetics.
Measurements
Blood samples
Upon participant arrival at the laboratory (V 1 ), a 20-gauge polyethylene catheter was inserted into a forearm vein for blood sampling. Blood samples were drawn at rest after an overnight fasting. Fasting blood glucose was measured using the hexokinase method (Roche Diagnosis, Indianapolis, IN). Glycated hemoglobin was assayed using the ion-exchange high-performance liquid chromatography method (Bio-Rad, Hercules, CA). Serum cholesterol, triglycerides and high-density lipoprotein-cholesterol were analyzed as previously described (21, 29) . Low-density lipoprotein-cholesterol was calculated using Friedewald's formula (30) . The cholesterol/highdensity lipoprotein ratio was also calculated. Resting left ventricular diastolic dysfunction (LVDD) was evaluated using standardized criteria (29, 34) . First, transmitral pulsed Doppler recordings were obtained to measure the following parameters: peak E velocity in cm/s (peak early transmitral filling velocity during early diastole), peak A velocity in cm/s (peak transmitral atrial filling velocity during late diastole), deceleration time in ms (time elapsed between peak E velocity and the point where the extrapolation of the deceleration slope of the E velocity crosses the zero baseline) and E/A ratio (peak E wave velocity divided by peak A wave velocity). In order to reduce the high filling pressures encountered in the pseudonormalized pattern of LV filling, the same measurements were repeated during phase II of the Valsalva maneuver (29) . Tissue Doppler velocities were measured at the mitral annular level of the LV septum, to provide additional information about filling pressure. Early (Ea) and late (Aa) velocities were measured and E/Ea ratio was calculated (35) . LVDD was characterized as normal, abnormal relaxation, pseudonormal pattern and restrictive pattern. Subjects had a normal LV diastolic function if a deceleration time between 140-240 msec, an E/A ratio between 1 and 2 and an E/Ea ratio < 8 were present. LVDD was characterized as abnormal relaxation if subjects had a deceleration time > 240 msec and an E/A ratio < 1. LVDD was characterized as a pseudonormal filling pattern if subjects had a deceleration time between 150-240 msec, an E/A ratio between 1 and 2 and an E/Ea ratio > 15 (36) , or a reduction in the E/A ratio > 0.5 following the Valsalva maneuver. Finally, LVDD was characterized as a restrictive filling pattern if subjects had a deceleration time < 140 msec and E/A ratio > 2.
Echocardiography
Pulmonary function tests
Standard pulmonary function tests, including body plethysmography, spirometry and singlebreath diffusing capacity of the lung for carbon monoxide [D LCO ] were performed in participants (37) .
Heart rate variability
Heart rate variability was derived from a 24-hour Holter monitoring system (Marquette Electronics, Milwaukee, WI) in all participants during normal daily life activity. Heart rate variability derived from 24-hour ambulatory monitoring is reproducible and free of placebo effect (38) . Within the 24-hour evaluation, three periods were arbitrarily assessed: 1) 24 hours, 2) daytime period defined as 8:00 AM to 8:00 PM and, 3) night-time period defined as 12:00 AM to 6:00 AM (23). In the frequency domain, power in the low-frequency (0.04 to 0.15 Hz), and highfrequency (0.15 to 0.4 Hz) ranges were calculated. The low frequency/high frequency ratio, considered to be a marker of the ratio of sympathetic to parasympathetic balance, was also determined (39) Heart rate was measured using electrocardiographic monitoring during the test. Participants exercised until volitional exhaustion. VO 2 max was defined as the mean VO 2 recorded in the last 15 seconds of the ramp protocol concurrent with a RER ≥ 1.15. The ventilatory threshold was evaluated with the V-slope method (40) . The exercise protocol was always performed at the same time of the day at a room temperature of 19 °C.
Square-wave exercise protocol
Each participant performed four square-wave exercise protocols, from unloaded pedaling to 80% ventilatory threshold, on four different visits separated by at least 48 hours. Pulmonary gas exchange and HR were continuously monitored during exercise.
Data analysis and statistics
VO 2 and HR kinetics analysis
Breath-by-breath data were filtered and linearly interpolated to provide second-by-second values, then time-aligned to the onset of exercise and ensemble-averaged into 5-s bins. The phase 1 response (approximately 20 seconds) was omitted (41) and a mono-exponential equation was used to fit the data (Origin software, OriginLab, Northampton, MA, USA):
where VO 2 (t) represents VO 2 as a function of time t; VO 2baseline represents the mean VO 2 in the baseline period (unloaded pedaling); Amp is the amplitude or the difference between the baseline and steady-state VO 2 , TD is the time delay before the onset of exercise and τVO 2 , the phase 2 time constant, representing the time required to reach 63 % of the steady-state response.
The same equation was used for the HR kinetics analysis, starting at time 0. Accordingly, there was not time delay incorporated into the model employed to describe HR kinetics.
Statistical analysis
The Mann-Whitney Rank Sum test was used to compare variables between groups. All data is presented as mean ± standard deviation unless otherwise specified. A p value < 0.05 was considered statistically significant. A sample size calculation was based on previous work that studied VO 2 kinetics (7, 42) in women with type 2 diabetes. Accordingly, 8 participants per group were necessary in order to report a statistically significant difference of 15±10 sec in τVO 2 between our two groups with a power of 80% and a p<0.05.
Results
Anthropometric characteristics, resting hemodynamics, metabolic profile (Table 1) , cardiac structures, baseline LV systolic function, heart rate variability (Table 2 ) and pulmonary function ( VO 2 max and cardiopulmonary responses at maximal exercise were similar between groups (Table 3 ). Both τVO 2 (43±6 vs. 43±10 s; p=0.73; Figure 1 ) and τHR (42±17 vs. 43±13 s; p=0.94; Figure 2 ) were similar between diabetics and control participants. Heart rate amplitude was greater in diabetics (p<0.05; Table 4 ). However, the other VO 2 and HR kinetics variables were similar between groups (Table 4 ). 
Discussion
The results of this study suggest that obese sedentary men with well-controlled type 2 diabetes without clinical complications or comorbidities do not show a reduction in VO 2 max or slower VO 2 and HR kinetics compared to participants without diabetes matched for sex, age and body mass index. In addition, diabetics and control participants had similar metabolic profile and resting cardiorespiratory function, which may explain the similar submaximal and maximal exercise capacity responses reported in this study.
Type 2 diabetes has been associated with reduced maximal exercise performance (2, (4) (5) (6) (7) (8) (9) (10) (11) 14) .
However, the exact underlying pathophysiological mechanisms are still ambiguous. In our study including well-matched participants, no difference in VO 2 max was observed between groups, in contrast to previous reports. It is noteworthy that in most of the studies that reported a reduction in VO 2 max in patients with diabetes, other important variables may have contributed to the reduced VO 2 max, such as poor glycemic control (14, 43, 44) , presence of LVDD (20, 21), reduced heart rate variability (20, 45) , impaired lung diffusion capacity or early signs of cardiac impairment altering pumping capacity (46, 47) and the presence of comorbidities associated with type 2 diabetes (13) . The presence of type 2 diabetes did not add additional burden to the majority of variables related to resting cardiopulmonary function in the present study. Since the cardiopulmonary function has an important influence on exercise performance in healthy individuals (47) , the absence of a deleterious impact of well-controlled, uncomplicated type 2 diabetes on VO 2 max in this study is not surprising. It is noteworthy that our participants with type 2 diabetes were treated with diet (n=4) or metformin alone (n=2) reinforcing the fact that their diabetes was not longstanding which may have required a more aggressive pharmacological intervention.
In addition, type 2 diabetes is usually associated with altered LV diastolic function (18, 45, 48, 49) . The negative impact of LVDD on submaximal exercise responses (8) and maximal exercise capacity (21) has been reported. Although a trend toward higher LV filling pressure was observed in diabetics vs. controls, a similar number of participants in both groups had LVDD, which could partly contribute to the comparable maximal exercise capacity between the two groups. What is still ambiguous pertaining to LVDD in diabetics is whether its appearance coincides with the development of diabetes or occurs earlier, since several variables such as blood pressure, age, sedentary lifestyle, obesity, hyperinsulinemia and LV systolic failure may modulate the development of LVDD (26, 27, 50) . Accordingly, the results of this study do not exclude that LVDD has a negative influence on exercise capacity in patients with type 2 diabetes (51) . Further research is necessary to isolate the influence of LVDD on VO 2 max in these patients.
The evaluation of VO 2 and HR kinetics provides supplemental mechanistic information on how a clinical population, in this case well-characterized men with well-controlled type 2 diabetes with short known disease duration, adapt to a transition from low to moderate intensity exercise.
Compared to VO 2 max, VO 2 and HR kinetics provide a more accurate evaluation of how participants adapt to everyday life activity, considering that they rarely perform activities at maximal exercise intensity. As VO 2 kinetics represents the efficiency of the cardiovascular and metabolic systems to respond to changes in demand, a slower VO 2 or HR adjustment at the onset of exercise is associated with a lower functional capacity and harder perceived effort when performing regular activities (16) . A slower response may be the result of impaired O 2 delivery, inappropriate distribution of O 2 to the working muscles, other muscular factors (metabolic inertia), or more likely, a combination of these factors (16) .
In our study, no difference in VO 2 kinetics was observed between groups. This contrasts with previous studies conducted in patients with type 2 diabetes, in which slower VO 2 kinetics has been reported (4, 6, 7, 15) . Factors that could have contributed to the slower VO 2 kinetics reported in previous studies include non-optimal short and long-term glycemic control, (52) . Interestingly, the slowed VO2 kinetics reported in uncomplicated type 2 diabetics could attain a plateau early following the onset of the disease, without a further detrimental impact of aging (15) .
The evaluation of HR kinetics provides a measure of central blood flow adjustment, and O 2 delivery, at the onset of moderate exercise (16) . Previous studies having investigated HR kinetics in type 2 diabetics provided equivocal observations. The adjustment of HR seems slower in pre and post-menopausal women (7, 10) , as well as in older men with type 2 diabetes with longer disease duration (9) or with sub-optimal glycemic control (10) . The difference between those results and ours may be attributable to the shorter disease duration of our cohort (< 5 years), the mean age of our participants and the optimal short and long-term glycemic control. In addition, diabetics involved in this study were treated with diet or metformin alone, compared to more advanced treatment (10) , which often reflects a more advanced form of diabetes or the presence of complications or comorbidities. To our knowledge, the present study is the first to show that well-characterized optimally-controlled men with type 2 diabetes and of a relatively short known disease duration (< 5 years) do not have slower HR kinetics compared to control subjects. In addition, it appears that the slowed HR kinetics may be influenced to a greater extent by other variables, such as age, fitness or the presence of comorbidities rather than the disease processes, at least in the early stage of diabetes.
This study has limitations that need to be discussed. We acknowledge that the number of participants in the present study was relatively low, only composed of men and the study did not include a lean control group. These factors limit the generalization of our results. Although 8 participants per group would have been necessary to report a statistically significant difference of 15±10 sec in τVO 2 between our groups based on previous reported data (7, 42), we did not reach such a sample size (diabetic group: n=6 and control group: n=7). However, it is highly unlikely that τVO 2 would have been different with the addition of 2 participants in the diabetic group and 1 participant in the control group taking into consideration that the difference in τVO 2 between groups was far from the ∼15 sec reported in the literature. By study design, participants in both groups had similar age and body mass index. They also had similar glycemic control, lipid profile, resting blood pressure, pulmonary function as well as cardiac autonomic system modulation. The majority of participants with diabetes were recently diagnosed, and all of them were well-controlled, while control participants may not be considered as completely "healthy" participants, considering their age, the presence of obesity in a majority of participants and the fact that they were physically inactive. We consider that the similarities observed between our groups is a strength of this study which permit to assess the impact of type 2 diabetes per se, and not the related complications, on submaximal and maximal exercise performance.
The number of square-wave exercise protocols used to model VO 2 and HR kinetics is also a strength of this study. Indeed, at least 3 transitions seem necessary to get an adequate signal-tonoise ratio (53) and previous studies that investigated VO 2 or HR kinetics in patients with type 2 diabetes did not all reach that prerequisite, which considerably reduces the precision in the modeling of the underlying physiologic responses during an exercise transition. Another important issue is that we allowed 48 hours between each exercise trial for the evaluation of VO 2 and HR kinetics, to ensure that insulin sensitivity-induced exercise returned to baseline value (54) , and that fatigue would not interfere with the results, considering the low level of physical fitness of our population. Finally, these results warrant further studies investigating the influence of well-controlled, uncomplicated type 2 diabetes on exercise performance. Still, these results have potential clinical implications. If the presence of type 2 diabetes eventually leads to a lower capacity to perform exercise (14) , the present study suggests that well-controlled type 2 diabetes is not always associated with a reduction in submaximal (VO 2 and HR kinetics) or maximal exercise performance (VO 2 max). A more likely interpretation of these results may be that exercise performance is already impaired prior to the diagnosis of type 2 diabetes, as observed in participants with metabolic syndrome and healthy first-degree relatives of patients with type 2 diabetes, in whom subclinical metabolic and/or cardiovascular abnormalities are present (55) (56) (57) .
In the eventuality that these findings are supported in further studies, it will reinforce the importance of strong early therapeutic actions in individuals prone to develop type 2 diabetes in order to delay the appearance of this metabolic disorder and preserve the individual's exercise capacity and quality of life.
In conclusion, the findings from this study suggest that well-controlled type 2 diabetes does not necessarily result in a reduction of VO 2 max and a slowing of VO 2 /HR kinetics over and above what can be expected in obese and sedentary individuals.
